SCM
AMGN icon

Suffolk Capital Management’s Amgen AMGN Stock Holding History

Suffolk Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-91,695
Closed -$14.1M – 137
2015
Q2 		$14.1M Buy
91,695
+5,265
+6% +$843K 1.67% 12
2015
Q1 		$13.8M Buy
86,430
+56,640
+190% +$8.92M 1.62% 13
2014
Q4 		$4.75M Buy
+29,790
New +$4.64M 0.58% 55

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Suffolk Capital Management's AMGN Position: Q3 2015 in Review

Suffolk Capital Management sold out of Amgen (AMGN) in Q3 2015, closing a stake of 91,695 shares — an estimated $14.1M sold.

Suffolk Capital Management first reported a position in AMGN in Q4 2014 and held it in 3 quarters. The position peaked at $14.1M in Q2 2015. 1,380 funds tracked by Wall St. Rank hold AMGN as of Q3 2015.

  • Suffolk Capital Management reported no remaining Amgen position as of Q3 2015 after selling out during the quarter.
  • Suffolk Capital Management sold 91,695 Amgen shares in Q3 2015, an estimated $14.1M.
  • Suffolk Capital Management first reported a position in Amgen in Q4 2014 and held it in 3 quarters.
  • Suffolk Capital Management's Amgen position peaked at $14.1M in Q2 2015.
  • 1,380 funds tracked by Wall St. Rank held Amgen as of Q3 2015.

Based on Suffolk Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.